Skip to main content

Gene Therapy & Redosing Strategy: IdeS Endopeptidase Mediated Cleavage of Preexisting Anti-AAV Neutralizing Antibodies For In Vivo Gene Therapy

IgG-Cleaving Endopeptidase is IgG specific cysteine protease

The IgG-cleaving enzyme (IdeS) is a recombinant cysteine protease derived from Steptococcus pyogenes, and produced in E. coli that cleaves all four classes of human IgG with high specificity.  IdeS hydrolyzed human IgG at Gly236 in the lower hinge region of the IgG heavy chains resulting in (Fab')2 and Fc fragments.

Administration of IdeS enzyme in human lowers the IgG level in serum

To test the safety and effectiveness of IdeS in humans, IdeS was administered to 25 highly HLA sensitized patients before the transplantation of a kidney from an HLA incompatible donor. The study was conducted based on the hypothesis that the effective removal of IgGs should reduce antibody-dependent cytotoxicity and rejection of grafts in the individuals. This study showed that the IdeS can be safely administered (5 out 38 had IdeS related adverse event) to reduce the total IgG level in these clinical subjects. (Jordon et al. NEJM 2017)


Administration of IdeS enable in vivo gene transfer in the presence of anti-AAV8 neutralizing antibodies

Highly prevalent preexisting and post-administration humoral immunity has severely limited the enrollment of subjects for clinical trial and redosing for a durable response. With promising evidence of safety and effectiveness of IdeS in kidney transplantation, Leborgne et al. (2020) tested the feasibility of the IdeS in the removal of anti-AAV8 IgG and neutralizing antibodies. The study has shown that IdeS effectively removed the anti-AAV8 IgG and neutralizing antibodies in murine model and non-human primates (representative figure below). The Factor IX and FactorVIII proteins were higher in the IdeS infused animals compared to the control suggesting that the removal of neutralizing antibodies increase transduction in the target site, and expression of the transgene. 



Conclusion
These studies showed the feasibility of IdeS administration in the removal of human IgGs and increase the expression of a transgene in the animal models. These proof of concept studies showed the alternative approach for the removal of IgGs in patients with high neutralizing antibodies against AAVs.  Because of the bacterial origin of IdeS, further investigation on immunogenicity against these proteins and associated safety is needed. 

References

Comments

Popular posts from this blog

Carbohydrate Metabolism: MCQs and answers on Glycolysis & Gluconeogenesis

                                      MCQ on Glycolysis & Gluconeogenesis 1) Which of the following enzyme is not involved in galactose metabolism? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 2) Which of the following enzyme is defective in galactosemia (type I) - a fatal genetic disorder in infants? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 3) In the liver, the accumulation of which of the following metabolite attenuates the inhibitory of ATP on phosphofructokinase? a) Glucose-6-Phosphate b) Citrate c) Fructose-1,6-Bisphosphate d) Fructose-2,6-Bisphosphate 4) Mutation in which of the following enzymes leads to a glycogen storage disease known as "Tarui’s disease"? a) Glucokinase b) Phosphofructokinase c) Phosphoglucomutase d) Pyruvate Kinase 5) E...

MCQs and Answers on cultivation (culture/incubation), Isolation and Identification of microorganisms: Medical Microbiology

40 plus questions - Multiple Choice Questions on Classification, Culture, and Identification of the microorganisms 1. Which of the following microorganism has the cocci cell shapes and sizes arranged usually in tetrad structures? a)  Streptococcus pneumoniae b)  Staphylococcus aureus c)  Chlamydia trachomatis d)  Neisseria meningitidis 2. What are the different growth morphology and cell structures used for the classification of fungi? Select all the correct answers: a) Yeast b) Mold c) Mycelia d) Protozoa 3. Which of the following media is formulated with additional nutrients to support the growth of fastidious or nutritionally demanding bacteria that may not grow well on basic media? a) Differential media b) Enriched media c) Nutrient agar (media) d) Selective media 4. Which of the following metabolic characteristic is a distinguishing characteristic and identification of colonies of  E. coli ? a) Hydrogen sulfide formation b) Indole Formation c) Lactose fe...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

                                        MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia.  Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance  c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells.  c) Patients with  uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above   3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose  c) Insulin ...